Takeda Pharmaceutical Company Limited

VelcadeBortezomib Cell Lymphoma

SHARE

Bortezomib (brand name: Velcade) is a treatment for multiple myeloma (a cancer of the plasma cells) and mantle cell lymphoma (a cancer of the lymph nodes).